Secondary sclerosing cholangitis.

Diagnosis of IgG4-related sclerosing cholangitis. World J Gastroenterol (2013) 1.32

Abdominal obesity and prolonged prone positioning increase risk of developing sclerosing cholangitis in critically ill patients with influenza A-associated ARDS. Eur J Med Res (2012) 0.94

Biliary cast formation with sclerosing cholangitis in critically ill patient: case report and literature review. Korean J Radiol (2012) 0.93

Update on Sclerosing Cholangitis in Critically Ill Patients. Viszeralmedizin (2015) 0.93

Obliterative portal venopathy: a clinical and histopathological review. Dig Dis Sci (2013) 0.84

Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis. Dtsch Arztebl Int (2013) 0.83

Rare case of severe cholangiopathy following critical illness. BMJ Case Rep (2014) 0.81

IgG4-related hepatobiliary disease: an overview. Nat Rev Gastroenterol Hepatol (2016) 0.78

Secondary Sclerosing Cholangitis due to Gallbladder Adenocarcinoma. Case Rep Gastroenterol (2013) 0.78

Controversies in the management of primary sclerosing cholangitis. World J Hepatol (2016) 0.76

Forsaken Foregut: Case Report of Simultaneous Black Esophagus and Ischemic Cholangiopathy. Case Rep Med (2017) 0.75

Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study. BMC Gastroenterol (2017) 0.75

Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis. World J Gastroenterol (2013) 0.75

An Imaging and Histological Study on Intrahepatic Microvascular Passage of Contrast Materials in Rat Liver. Biomed Res Int (2017) 0.75

Secondary sclerosing cholangitis in critically ill patients: current perspectives. Clin Exp Gastroenterol (2017) 0.75

NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients. Sci Rep (2017) 0.75

A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis. Virchows Arch (2014) 0.75

High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med (2001) 12.49

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol (2004) 2.81

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology (2002) 2.64

The cholangiopathies: disorders of biliary epithelia. Gastroenterology (2004) 2.38

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology (2004) 2.02

Bile composition and bile cast formation after transplantation of the liver in man. Transplantation (1975) 1.92

Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol (2007) 1.88

Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med (2006) 1.78

Ischemic cholangitis in hepatic allografts. Mayo Clin Proc (1992) 1.66

Pathophysiology of cholangiopathies. J Clin Gastroenterol (2005) 1.63

A simple modification in operative technique can reduce the incidence of nonanastomotic biliary strictures after orthotopic liver transplantation. Hepatology (1995) 1.59

Endoscopic management of postoperative biliary complications in orthotopic liver transplantation. Gastrointest Endosc (2000) 1.57

Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant (2003) 1.46

MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis (2007) 1.42

Sclerosing cholangitis: a focus on secondary causes. Hepatology (2006) 1.37

Biliary complications of orthotopic liver transplantation. Dig Dis (1999) 1.29

The pathology of cholestasis. Semin Liver Dis (2004) 1.27

Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy (2002) 1.23

Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis. Am J Gastroenterol (2003) 1.23

The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology (1987) 1.19

Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol (1985) 1.19

Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am J Physiol (1999) 1.14

The development of biliary "sludge" following liver transplantation. Transplant Proc (1979) 1.14

Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg (1993) 1.11

Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis. Am J Gastroenterol (2005) 1.10

AIDS-related cholangitis: diagnostic features and course in 15 patients. J Hepatol (1993) 1.08

Cholangiopathy and the biliary cast syndrome. Eur J Gastroenterol Hepatol (2003) 1.06

Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut (2003) 1.05

Cholangiocyte injury and ductopenic syndromes. Semin Liver Dis (2007) 1.05

The effect of scolicidal agents on liver and biliary tree (experimental study). J Invest Surg (2005) 1.05

Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up. Endoscopy (2006) 1.04

Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms. World J Gastroenterol (2005) 1.02

Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep (2003) 1.01

Pathophysiology of the intrahepatic biliary epithelium. J Gastroenterol Hepatol (2000) 1.01

Ischemic cholangitis. Mayo Clin Proc (1998) 1.00

Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology (1985) 1.00

Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases. Crit Care Med (2001) 0.99

Biliary sludge-cast formation following liver transplantation. Hepatogastroenterology (1988) 0.98

Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis. Virchows Arch (2008) 0.97

Postreperfusion biopsies are useful in predicting complications after liver transplantation. Liver Transpl (2001) 0.97

Ischemic cholangiopathy after liver transplantation. Hepatobiliary Pancreat Dis Int (2005) 0.96

Eosinophilic cholangiopathy. Gastrointest Endosc (1997) 0.95

Ischemic cholangiopathy. J Hepatol (2006) 0.94

Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey. Hum Pathol (1994) 0.94

The effects of mechanical ventilation on the gut and abdomen. Curr Opin Crit Care (2006) 0.93

Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy (2008) 0.92

Short and long-term effects of bacterial translocation due to obstructive jaundice on liver damage. Hepatogastroenterology (2003) 0.88

Satellite cysts and biliary fistulas in hydatid liver disease. A retrospective study of 17 liver resections. Hum Pathol (2007) 0.88

AIDS Cholangiopathy. Curr Treat Options Gastroenterol (2004) 0.87

Vasoactive drugs and the gut: is there anything new? Curr Opin Crit Care (2006) 0.86

Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol (1995) 0.86

Aggressive systemic mastocytosis mimicking sclerosing cholangitis. Haematologica (2004) 0.85

The complex functions of mast cells in chronic human liver diseases. Dig Dis Sci (2006) 0.85

Ischemic-type biliary strictures in liver allografts: the Achilles heel revisited? Hepatology (1995) 0.84

Microsporidial AIDS cholangiopathy due to Encephalitozoon intestinalis: case report and review. Am J Gastroenterol (2000) 0.82

Pathogenesis of sclerosing cholangitis: the role of nonimmune factors. Semin Liver Dis (1991) 0.81

Sclerosing cholangitis associated to cryptosporidiosis in liver-transplanted children. Eur J Pediatr (2000) 0.81

The influence of cold ischemia time on biliary complications following liver transplantation. J Hepatol (1994) 0.80

Rejection of ABO incompatible liver allografts in man. Transplant Proc (1989) 0.80

Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient. J Hepatol (2003) 0.80

Recurrent cholestasis and hypereosinophilia in a young female. Dig Liver Dis (2000) 0.79

Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis. Endoscopy (2008) 0.79

Mast cell cholangiopathy: another cause of sclerosing cholangitis. Gastroenterology (1995) 0.79

Ischemia and cholestasis: more than (just) the bile ducts! Transplantation (2008) 0.78

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology (2006) 3.18

The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen (2004) 2.94

WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol (2003) 2.30

Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol (2007) 2.02

Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A (2007) 1.97

Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. Eur Urol (2007) 1.89

Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest (2006) 1.78

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Eur Urol (2007) 1.72

Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Exp Cell Res (2005) 1.63

Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer. J Pathol (2005) 1.60

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. Breast Cancer Res (2008) 1.40

High frequency of FGFR3 mutations in adenoid seborrheic keratoses. J Invest Dermatol (2006) 1.37

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest (2004) 1.35

Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin Cancer Res (2007) 1.33

Potential of fibroblasts to regulate the formation of three-dimensional vessel-like structures from endothelial cells in vitro. Am J Physiol Cell Physiol (2006) 1.31

Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Int J Cancer (2007) 1.30

The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma. Int J Cancer (2010) 1.29

Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. J Pathol (2004) 1.26

Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res (2002) 1.24

Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res (2002) 1.20

Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J Invest Dermatol (2007) 1.13

Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Hum Pathol (2007) 1.10

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Cancer Immunol Immunother (2009) 1.08

Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol (2009) 1.07

Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease. Clin J Am Soc Nephrol (2008) 1.05

Fibrin glue in the endoscopic treatment of fistulae and anastomotic leakages of the gastrointestinal tract. Int J Colorectal Dis (2010) 1.03

Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation. Scand J Gastroenterol (2010) 1.03

Fibroadenoma of the axilla. Dermatol Surg (2005) 1.02

No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Int J Oncol (2002) 1.01

Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. Oncol Rep (2007) 1.01

Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study. Thyroid (2002) 1.01

Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: an approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation. Virchows Arch (2007) 1.01

Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int J Oncol (2005) 1.00

Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark (2007) 0.98

Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series. Histopathology (2011) 0.97

Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder. Int J Cancer (2006) 0.96

Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase. J Clin Pathol (2006) 0.92

Autocrine fibronectin-induced migration of human colonic fibroblasts. Am J Gastroenterol (2004) 0.92

Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Exp Dermatol (2010) 0.91

Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch (2014) 0.91

Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts. Immunobiology (2010) 0.90

Spontaneous rupture of a benign giant adrenal adenoma. APMIS (2007) 0.88

Gastrointestinal manifestation of systemic sclerosis--thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign. Rheumatology (Oxford) (2009) 0.88

Microsatellite instability at chromosome 8p in non-small cell lung cancer is associated with lymph node metastasis and squamous differentiation. Int J Oncol (2003) 0.88

FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization. Mod Pathol (2007) 0.88

Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clones. Lab Invest (2002) 0.86

Presence of HER4 associates with increased sensitivity to Herceptin in patients with metastatic breast cancer. Breast Cancer Res (2009) 0.86

Flow cytometric analysis of peripheral blood lymphocyte subsets in patients with silicone breast implants. Plast Reconstr Surg (2008) 0.86

Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis. Cancer Epidemiol Biomarkers Prev (2009) 0.85

Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology. J Mol Diagn (2005) 0.83

Microwave-assisted tissue processing for same-day EM-diagnosis of potential bioterrorism and clinical samples. Micron (2006) 0.83

P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype. Pathobiology (2011) 0.83

Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors. Arch Dermatol (2006) 0.83

LPS-mediated NFkappaB activation varies between activated human hepatic stellate cells from different donors. Biochem Biophys Res Commun (2004) 0.83

Tissue microarray construction from bone marrow biopsies. Biotechniques (2005) 0.82

Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium. Am J Clin Pathol (2005) 0.82

Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract. Am J Surg Pathol (2007) 0.82

A potential predictive marker for response to interferon in malignant melanoma. J Dtsch Dermatol Ges (2007) 0.81

MethyQESD, a robust and fast method for quantitative methylation analyses in HNPCC diagnostics using formalin-fixed and paraffin-embedded tissue samples. Lab Invest (2008) 0.81

Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma. Oncol Rep (2005) 0.80

Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinoma. Pathobiology (2012) 0.80

Patients with localised prostate cancer (t1 - t2) show improved overall long-term survival compared to the normal population. J Cancer (2011) 0.80

p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort. Oncol Rep (2007) 0.79

NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians. Int J Mol Sci (2012) 0.78

Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitations. Cytometry A (2010) 0.78

Hexaminolevulinate-induced fluorescence endoscopy in patients with rectal adenoma and cancer: a pilot study. Gastrointest Endosc (2004) 0.78

Complicated wireless capsule enteroscopy in a patient with Crohn's disease. Eur J Gastroenterol Hepatol (2009) 0.77

A new grading system to evaluate the risk of endoscopic retrograde cholangiopancreatography. J Gastroenterol (2009) 0.77

Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients. Oncol Rep (2004) 0.77

Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors. Eur Arch Otorhinolaryngol (2013) 0.77

Development of de novo cancer in p53 knock-out mice is dependent on the type of long-term immunosuppression used. Transplantation (2006) 0.76

Persistent histological changes in the exstrophic bladder after primary closure-a cause for concern? J Urol (2012) 0.76

The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo. J Invest Dermatol (2009) 0.76

Male infertility: assessment of juvenile testicular dysfunction and risk for malignancy in cryptorchid boys based on resin section evaluation. Ultrastruct Pathol (2013) 0.76

No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract. Oncol Rep (2004) 0.75

Extrusion forces of resorbable tacks and titanium screws in laryngeal chondrosynthesis. Eur Arch Otorhinolaryngol (2006) 0.75

[Detection of lymph node metastases of malignant melanoma by palpation and ultrasound]. Med Klin (Munich) (2003) 0.75

Multiple molecular analyses from minimal cell quantities by sequential isolation and preamplification of DNA and RNA. Diagn Mol Pathol (2007) 0.75

Expression and potential clinical significance of urothelial cytodifferentiation markers in the exstrophic bladder. J Urol (2012) 0.75